**Core Concept**
The question is testing the ability to identify a specific immunohistochemical marker useful for diagnosing a tumor type in the bronchus. This requires knowledge of the molecular characteristics of various lung tumors and the role of immunohistochemistry in differential diagnosis.

**Why the Correct Answer is Right**
The correct answer is based on the fact that the tumor type in question is likely to be a type of lung cancer that can be identified by a specific immunohistochemical marker. Immunohistochemistry is a valuable tool for distinguishing between different types of lung cancer, including adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. For a tumor resected from the bronchus of a chronic smoker, the most useful marker would be one that is specific for a type of lung cancer that is commonly associated with smoking.

**Why Each Wrong Option is Incorrect**
* **Option A:** This marker is not typically used for diagnosing lung cancer. It is more commonly associated with other types of tumors.
* **Option B:** This marker is not specific for the type of lung cancer that is most commonly associated with smoking.
* **Option C:** This marker is not typically used for diagnosing lung cancer, and it may not be specific for the type of tumor in question.

**Clinical Pearl / High-Yield Fact**
When diagnosing lung cancer, it's essential to consider the patient's smoking history and the specific location of the tumor within the bronchus. A tumor located in the central bronchus is more likely to be a type of lung cancer that is associated with smoking, such as squamous cell carcinoma.

**Correct Answer:** C. TTF-1 (Thyroid Transcription Factor-1) is a useful marker for identifying adenocarcinoma, a type of lung cancer that is commonly associated with smoking.